|
|
- 2015
血脂康对实验性自身免疫性神经炎的治疗潜能
|
Abstract:
| [1] | Xia RH, Yosef N, Ubogu EE. Clinical, electrophysiological and pathologic correlations in a severe murine experimental autoimmune neuritis model of Guillain-Barre syndrome[J]. J Neuroimmunol, 2010, 219(1-2):54-63. |
| [2] | Zhang X, Tao Y, Wang J, et al. Simvastatin inhibits secretion of Th17-polarizing cytokines and antigen presentation by DCs in patients with relapsing remitting multiple sclerosis[J]. Eur J Immunol, 2013, 43(1):281-289. |
| [3] | Myhr KM, Vagnes KS, Maroy TH, et al. Interleukin-10 promoter polymorphisms in patients with Guillain-Barre syndrome[J]. J Neuroimmunol, 2003, 139(1-2):81-83. |
| [4] | Doreau A, Belot A, Bastid J, et al. Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus[J]. Nat Immunol, 2009, 10(7):778-785. |
| [5] | Li XL, Liu Y, Cao LL, et al. Atorvastatin-modified dendritic cells in vitro ameliorate experimental autoimmune myasthenia gravis by up-regulated Treg cells and shifted Th1/Th17 to Th2 cytokines[J]. Mol Cell Neurosci, 2013, 56:85-95. |
| [6] | Deng H, Yang X, Jin T, et al. The role of IL-12 and TNF-alpha in AIDP and AMAN[J]. Eur J Neurol, 2008, 15(10):1100-1105. |
| [7] | Sabat R, Grutz G, Warszawska K, et al. Biology of interleukin-10[J]. Cytokine Growth Factor Rev, 2010, 21(5):331-344. |
| [8] | O'Garra A, Barrat FJ, Castro AG, et al. Strategies for use of IL-10 or its antagonists in human disease[J]. Immunol Rev, 2008, 223:114-131. |
| [9] | Li H, Li XL, Zhang M, et al. Berberine ameliorates experimental autoimmune neuritis by suppressing both cellular and humoral immunity[J]. Scand J Immunol, 2014, 79(1):12-19. |
| [10] | Nicholls SJ, Pisaniello AD, Kataoka Y, et al. Lipid pharmacotherapy for treatment of atherosclerosis[J]. Expert Opin Pharmacother, 2014, 15(8):1119-1125. |
| [11] | Zhang X, Jin J, Peng X, et al. Simvastatin inhibits IL-17 secretion by targeting multiple IL-17-regulatory cytokines and by inhibiting the expression of IL-17 transcription factor RORC in CD4<sup>+</sup> lymphocytes[J]. J Immunol, 2008, 180(10):6988-6996. |
| [12] | 蓝晓红, 周永刚. 血脂康胶囊致横纹肌溶解症1例[J]. 中国药物警戒, 2010, 7(4):255-256. |
| [13] | Bao L, Lindgren JU, Zhu Y, et al. Exogenous soluble tumor necrosis factor receptor type I ameliorates murine experimental autoimmune neuritis[J]. Neurobiol Dis, 2003, 12(1):73-81. |
| [14] | Zhang HL, Zheng XY, Zhu J. Th1/Th2/Th17/Treg cytokines in Guillain-Barre syndrome and experimental autoimmune neuritis[J]. Cytokine Growth Factor Rev, 2013, 24(5):443-453. |
| [15] | Hofstetter HH, Ibrahim SM, Koczan D, et al. Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis[J]. Cell Immunol, 2005,237(2):123-130. |
| [16] | Reise Sousa C. Dendritic cells in a mature age[J]. Nat Rev Immunol, 2006, 6(6):476-483. |
| [17] | Li XL, Dou YC, Liu Y, et al. Atorvastatin ameliorates experimental autoimmune neuritis by decreased Th1/Th17 cytokines and up-regulated T regulatory cells[J]. Cell Immunol, 2011, 271(2):455-461. |
| [18] | Yang CW, Mousa SA. The effect of red yeast rice (Monascus purpureus) in dyslipidemia and other disorders[J]. Complement Ther Med, 2012, 20(6):466-474. |
| [19] | Tang TT, Song Y, Ding YJ, et al. Atorvastatin upregulates regulatory T cells and reduces clinical disease activity in patients with rheumatoid arthritis[J]. J Lipid Res, 2011, 52(5):1023-1032. |
| [20] | Xiao Y, Liang L, Pan Y, et al. Inhibitory effects of simvastatin on migration and invasion of rheumatoid fibroblast-like synoviocytes by preventing geranylgeranylation of RhoA[J]. Rheumatol Int, 2013, 33(2):389-399. |
| [21] | 王慧力, 唐长华, 王芳. 血脂康不良反应[J]. 中国误诊学杂志, 2010, 10(6):1496-1501. |
| [22] | Li S, Yu M, Li H, et al. IL-17 and IL-22 in cerebrospinal fluid and plasma are elevated in Guillain-Barre syndrome[J]. Mediators Inflamm, 2012, 2012:260473. doi: 10.1155/2012/260473. |
